Epsilon Healthcare Ltd (ASX:EPN) is the new name for THC Global Group Ltd after shareholders approved the change last month.
The healthcare and pharmaceuticals company with an emphasis on medicinal cannabis now trades under the ASX code EPN.
Re-branding reflects “current approach”
Group chief executive officer Jarrod White said: “The complete rebranding of the company to Epsilon Healthcare Limited better reflects the company’s current approach as a healthcare and pharmaceuticals business with significant investment in the medicinal cannabis space in Australia and Canada.
“We look forward to continuing to develop our high-value pharmaceuticals manufacturing business in Southport, our healthcare clinics, the Medimar platform and our hydroponic cultivation service offerings globally under this new brand and strategy”.
Diversifed global healthcare company
Epsilon is a diversified global healthcare and pharmaceuticals company and owns a number of medicinal cannabis assets.
These assets include the largest cannabis manufacturing facility in the Southern Hemisphere, the Tetra Health clinic group and the Medimar Platform – an end-to-end ecommerce solution for nutraceuticals and cannabis.
EPN additionally operates a turn-key cannabis cultivation solutions provider based in Vancouver, Canada.